IL6 and skin disorder: Importantly, there were not any differences between MR16-1-treatment and IgG Ctrl-treatment in littermate Ctrl mice, highlighting the significance of IL-6 blockade therapy for the regulation of PD-1 signal blockade-activated CD8 T cells in psoriasis-like dermatitis.